retatrutide trial results weight loss Retatrutide, a new drug not available on the market yet, is showing promising in trials. Dr. LaPook explains it’s doing much more than what current medications can Survodutide vs. Retatrutide for Weight

For context on the broader landscape, understanding how mazdutide compares to tirzepatide and how cagrilintide fits in shows just how active the GLP-1 research space has become

Nat Rev Endocrinol 2012;8:728-42

However, treatment with 10 nM of exendin4 in these cell lines did not induce apoptosis

Clinical trials have demonstrated significant weight loss with semaglutide, with studies reporting an average body weight reduction of approximately 13.7% [1]

Luca Cantarini and Bruno Frediani contributed to the interpretation of the results through critical discussion

High-quality protein sources such as lean meats, fish, eggs, legumes, and dairy products should be incorporated into meals to optimise postprandial GLP-1 secretion